Anti-Aggregative Therapy and Laser Iridectomy

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00426400

Enrollment

Unknown

Registered

2007-01-24

Start date

2006-03-31

Completion date

Unknown

Last updated

2007-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyes With Narrow Angle

Brief summary

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patients will undergo first laser treatment with the anti-aggregative treatment and will scheduled for next lase in the other eye after discontinuing the anti-aggregative treatment. The patients will be followed-up for 3 months.

Interventions

DRUGThe cessation of anti-aggregative treatment for 10 days

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients with narrow angle that need laser iridectomy and take anti- aggregative treatment * over 20 years old * patients who can stop their anti-aggregative treatment for 10 days

Exclusion criteria

* under coumadin treatment * post ocular surgeries

Countries

Israel

Contacts

Primary ContactHani Levkovitch-Verbin, MD

Hani.Verbin@ sheba.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026